A Phase 2 Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of HRS-7085 Tablets in Patients With Inflammatory Bowel Disease
Latest Information Update: 21 Nov 2025
At a glance
- Drugs HRS 7085 (Primary)
- Indications Inflammatory bowel diseases; Ulcerative colitis
- Focus Adverse reactions
- Sponsors Shandong Suncadia Medicine
Most Recent Events
- 21 Nov 2025 New trial record